Table 2.

Disease and Survival Outcomes by Pre-Transplant Characteristics (Univariate)

		OS			PFS
Characteristic	N	Deaths	2-year estimate (SE)	P-value	Events	2-year estimate (SE)	P-value
All Patients	149	73	51% (5%)		84	42% (5%)
MRD Pre-Transplant				0.22			0.08
No	117	53	55% (5%)		60	47% (5%)
Yes	32	20	40% (10%)	OS	24	28% (8%)	PFS
MRD Pre-Transplant				0.46			0.19
No (0)	117	53	55% (5%)		60	47% (5%)
Low (≤0.1)	17	10	38% (13%)		11	34% (12%)
High (>0.1)	15	10	44% (14%)		13	21% (11%)
Age				0.02			0.05
<40 years	89	40	59% (6%)		47	47% (6%)
≥40 years	60	33	38% (8%)		37	33% (7%)
Sex				0.05			0.16
Male	91	50	45% (6%)		54	37% (6%)
Female	58	23	61% (7%)		30	49% (7%)
Disease Status				0.08			0.07
1st CR/CRi	72	29	63% (6%)		36	51% (7%)
Later CR/CRi	77	44	41% (6%)		48	34% (6%)
Cytogenetic Risk				0.98			0.71
High	80	39	55% (6%)		47	44% (6%)
Intermediate/Good	54	26	48% (8%)		29	39% (7%)
Phenotype				0.70			0.67
T cell	20	10	31% (13%)		11	33% (12%)
B cell	129	63	54% (5%)		73	44% (5%)
Conditioning Regimen				0.50			0.22
TBI	39	21	60% (8%)		22	52% (8%)
nonTBI	110	52	47% (6%)		62	37% (6%)
Allotype				0.21			0.57
Matched Related	84	38	53% (6%)		47	43% (6%)
Matched Unrelated	65	35	49% (7%)		37	42% (7%)
Cell Type				0.19			0.11
PB (HPC-A)	102	53	48% (5%)		62	40% (5%)
BM (HPC-M)	47	20	59% (8%)		22	48% (8%)